Literature DB >> 16160585

Psychological disorders and distress after adult cardiothoracic transplantation.

Mary Amanda Dew1, Andrea F DiMartini.   

Abstract

This review summarizes and integrates evidence concerning mental health outcomes following heart, lung, and heart-lung transplantation. Drawing on English-language case reports and empirical studies published between January 1980 and December 2004, the goals of the review were to (a) describe the prevalence and clinical characteristics of psychological disorders, as well as the level and pattern of clinically significant distress in the years posttransplant; (b) review the major risk factors for poor posttransplant psychological outcomes; (c) consider evidence suggesting that posttransplant psychological outcomes predict physical morbidity and mortality after transplant; (d) summarize findings from intervention studies designed to improve posttransplant psychological outcomes; and (e) provide patient care recommendations for the practicing clinician and recommendations for continued clinical research. Several major conclusions can be drawn from this literature. First, depressive and anxiety-related disorders and associated distress are common posttransplant. While new onsets of disorder may decline after the first year posttransplant, the development of new medical complications in the late years posttransplant may provoke renewed distress and recurrences of disorder. Second, risk factors for posttransplant psychological disorders and elevated distress include both standard risk factors observed in other populations (eg, younger age, lifetime history of psychiatric disorder) and transplant-specific factors related to physical functional impairments, social supports, and strategies for coping with health problems. Third, while little evidence has been published to date, there is some indication that posttransplant psychological outcomes can predict subsequent physical health outcomes. Fourth, extremely few intervention studies in cardiothoracic transplant recipients have been performed. The few reports indicate that multicomponent psychosocial strategies focused on risk factor reduction and enhancement of personal coping resources may lead to reductions in psychological distress. An important caveat in considering all of the evidence reviewed is that most studies focus on heart rather than lung or heart-lung recipients. Recommendations for practicing clinicians focus on assessment and treatment options, based on the evidence to date. Research recommendations focus on the need for intervention effectiveness studies.

Entities:  

Mesh:

Year:  2005        PMID: 16160585     DOI: 10.1097/00005082-200509001-00007

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  19 in total

1.  Poor sleep in organ transplant recipients: self-reports and actigraphy.

Authors:  M Reilly-Spong; T Park; C R Gross
Journal:  Clin Transplant       Date:  2013-10-01       Impact factor: 2.863

2.  Effect of Lung Transplantation on Health-Related Quality of Life in the Era of the Lung Allocation Score: A U.S. Prospective Cohort Study.

Authors:  J P Singer; P P Katz; A Soong; P Shrestha; D Huang; J Ho; M Mindo; J R Greenland; S R Hays; J Golden; J Kukreja; M E Kleinhenz; R J Shah; P D Blanc
Journal:  Am J Transplant       Date:  2017-01-03       Impact factor: 8.086

3.  Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Annette J DeVito Dabbs; Kristen R Fox; Larissa Myaskovsky; Donna M Posluszny; Galen E Switzer; Rachelle A Zomak; Robert L Kormos; Yoshiya Toyoda
Journal:  Gen Hosp Psychiatry       Date:  2012-01-14       Impact factor: 3.238

4.  Factors associated with stress and coping at 5 and 10 years after heart transplantation.

Authors:  Kathleen L Grady; Edward Wang; Connie White-Williams; David C Naftel; Susan Myers; James K Kirklin; Bruce Rybarczyk; James B Young; Dave Pelegrin; Jon Kobashigawa; Robert Higgins; Alain Heroux
Journal:  J Heart Lung Transplant       Date:  2013-04       Impact factor: 10.247

Review 5.  Depression and Anxiety as Risk Factors for Morbidity and Mortality After Organ Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Mary Amanda Dew; Emily M Rosenberger; Larissa Myaskovsky; Andrea F DiMartini; Annette J DeVito Dabbs; Donna M Posluszny; Jennifer Steel; Galen E Switzer; Diana A Shellmer; Joel B Greenhouse
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

6.  Quality of recipient-caregiver relationship and psychological distress are correlates of self-care agency after lung transplantation.

Authors:  Annette DeVito Dabbs; Lauren Terhorst; Mi-Kyung Song; Diana A Shellmer; Jill Aubrecht; Mary Connolly; Mary Amanda Dew
Journal:  Clin Transplant       Date:  2012-09-24       Impact factor: 2.863

Review 7.  LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant.

Authors:  Anne K Eshelman; Shawn Mason; Hassan Nemeh; Celeste Williams
Journal:  Heart Fail Rev       Date:  2008-01-24       Impact factor: 4.214

8.  Psychosocial Predictors of Mortality Following Lung Transplantation.

Authors:  P J Smith; J A Blumenthal; E P Trulock; K E Freedland; R M Carney; R D Davis; B M Hoffman; S M Palmer
Journal:  Am J Transplant       Date:  2015-09-14       Impact factor: 8.086

Review 9.  Psychiatric aspects of organ transplantation in critical care.

Authors:  Andrea DiMartini; Catherine Crone; Marian Fireman; Mary Amanda Dew
Journal:  Crit Care Clin       Date:  2008-10       Impact factor: 3.598

10.  Patterns and predictors of quality of life at 5 to 10 years after heart transplantation.

Authors:  Kathleen L Grady; David C Naftel; Jon Kobashigawa; Julie Chait; James B Young; Dave Pelegrin; Jennifer Czerr; Alain Heroux; Robert Higgins; Bruce Rybarczyk; Mary McLeod; Connie White-Williams; James K Kirklin
Journal:  J Heart Lung Transplant       Date:  2007-03-26       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.